Special Issue on Drug Therapy and Disease Control
Drug
Therapy and Disease Control covers the development, application,
evaluation, and optimization of pharmacological interventions for the
prevention, treatment, and management of diseases. Key areas include drug
discovery and development, pharmacotherapy, antimicrobial therapy, antiviral
and antiparasitic treatments, oncology therapeutics, cardiovascular and
metabolic disease management, immunotherapy, personalized medicine, drug
safety, pharmacovigilance, drug resistance, and therapeutic efficacy. The field
also considers evidence-based treatment strategies, medication adherence, drug
interactions, clinical outcomes, and the integration of pharmacological
approaches with public health measures to improve disease prevention, disease
control, and patient care.
In this special issue, we intend to invite
front-line researchers and authors to submit original research and review
articles on exploring Drug Therapy and Disease Control. Potential topics include, but are not limited to:
-
Pharmacotherapy
-
Drug development
-
Antimicrobial therapy
-
Antiviral therapy
-
Antiparasitic therapy
-
Anticancer therapy
-
Immunotherapy
-
Cardiovascular therapeutics
-
Metabolic disease therapy
-
Neurological therapeutics
-
Infectious disease control
-
Drug resistance
-
Pharmacovigilance
-
Personalized medicine
-
Therapeutic drug monitoring
-
Medication adherence
Authors should read over the journal’s For Authors carefully before submission. Prospective authors should submit an electronic
copy of their complete manuscript through the journal’s Paper Submission
System.
Please kindly specify the “Special Issue”
under your manuscript title. The research field “Special Issue - Drug
Therapy and Disease Control” should be selected during your submission.
Special Issue Timetable:
|
Submission Deadline
|
December 10th, 2026
|
|
Publication Date
|
February 2027
|
Guest Editor:
For
further questions or inquiries, please contact Editorial Assistant at [email protected].